Retraction: Involvement of Nrf2-mediated upregulation of heme oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human oral cancer cells (BioMed Research International (2013) 2013 (210604) DOI: 10.1155/2013/210604);Involvement of Nrf2-mediated upregulation of heme oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human oral cancer cells

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Lee, Young Man ^a   Auh, Q Schick ^a   Lee, Deok Won ^a   Kim, Jun Yeol ^a   Jung, Ha Jin ^a   Lee, Seung Ho ^b   Kim, Eun Cheol ^a  

^a Kyung Hee University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; FIBROBLAST GROWTH FACTOR 2; FLUORESCEIN ISOTHIOCYANATE; GELATINASE B; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MOLLUGIN; PLANT MEDICINAL PRODUCT; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VASCULOTROPIN; PYRAN DERIVATIVE; RUBIMAILLIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; BIOLOGICAL MODEL; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUTH TUMOR; PATHOLOGY; REPRODUCIBILITY; TUMOR CELL LINE; DRUG EFFECTS; MOUTH NEOPLASMS;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEME OXYGENASE-1; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MOUTH NEOPLASMS; NF-E2-RELATED FACTOR 2; NF-KAPPA B; PYRANS; REPRODUCIBILITY OF RESULTS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84878164148     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2020/1915927     Document Type: Erratum

References (47)

1. Schliephake H., Prognostic relevance of molecular markers of oral cancer-a review. International Journal of Oral and Maxillofacial Surgery 2003 32 3 233 245 2-s2.0-0037864294 10.1054/ijom.2002.0383 (Pubitemid 36700729)
2. Yamachika E., Habte T., Oda D., Artemisinin: an alternative treatment for oral squamous cell carcinoma. Anticancer Research 2004 24 4 2153 2160 2-s2.0-4444240287 (Pubitemid 39166289)
3. McCann J., Texas center studies research alternative treatments. Journal of the National Cancer Institute 1997 89 20 1485 1486 2-s2.0-0031572517
4. Lee J., Lee H. J., Park J. D., Lee S. K., Lee S. I., Lim H. D., Lee Y. M., Yun Y. G., Jeon B. H., Ree I. S., Jun C. D., Lee S. K., Kim E. C., Anti-cancer activity of highly purified sulfur in immortalized and malignant human oral keratinocytes. Toxicology in Vitro 2008 22 1 87 95 2-s2.0-37249033214 10.1016/j.tiv.2007.08.016 (Pubitemid 350267115)
5. WAF1/CIP1 in head and neck cancer cells. The American Journal of Chinese Medicine 2005 33 3 405 414 2-s2.0-21344475106 10.1142/S0192415X05003016 (Pubitemid 40909138)
6. Lee H. J., Son D. H., Lee S. K., Lee J., Jun C. D., Jeon B. H., Lee S. K., Kim E. C., Extract of Coptidis rhizoma induces cytochrome-c dependent apoptosis in immortalized and malignant human oral keratinocytes. Phytotherapy Research 2006 20 9 773 779 2-s2.0-33748809213 10.1002/ptr.1956 (Pubitemid 44408658)
7. Yun Y. G., Jeon B. H., Lee J. H., Lee S. K., Lee H. J., Jung K. H., Jun-Lee, Jun C. D., Lee S. K., Kim E. C., Verticinone induces cell cycle arrest and apoptosis in immortalized and malignant human oral keratinocytes. Phytotherapy Research 2008 22 3 416 423 2-s2.0-40849094364 10.1002/ptr.2345 (Pubitemid 351397448)
8. Lee Y. M., Jeong G. S., Lim H. D., An R. B., Kim Y. C., Kim E. C., Isoliquiritigenin 2′-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1. Toxicology in Vitro 2010 24 3 776 782 2-s2.0-77649180814 10.1016/j.tiv.2009.12.024
9. Lee Y. M., Kim Y. C., Kim E. C., Mechanism of sappanchalcone-induced growth inhibition and apoptosis in human oral cancer cells. Toxicology in Vitro 2011 25 8 1782 1788 10.1016/j.tiv.2011.09.009
10. Son J. K., Jung S. J., Woo M. H. M. H., Anticancer constituents from the roots of Rubia cordifolia L. Chemical Pharmacology Bulletin 2008 56 2 213 216 10.1248/cpb.56.213 (Pubitemid 351206651)
11. Chang L. C., Chavez D., Gills J. J., Fong H. H. S., Pezzuto J. M., Kinghorn A. D., Rubiasins A-C, new anthracene derivatives from the roots and stems of Rubia cordifolia. Tetrahedron Letters 2000 41 37 7157 7162 2-s2.0-0034601645
12. Tse W. P., Cheng C. H. K., Che C. T., Zhao M., Lin Z. X., Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: implications for psoriasis treatment. International Journal of Molecular Medicine 2007 20 5 663 672 2-s2.0-38449102690
13. Kim K. J., Lee J. S., Kwak M. K., Choi H. G., Yong C. S., Kim J. A., Lee Y. R., Lyoo W. S., Park Y. J., Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF- B activation. European Journal of Pharmacology 2009 622 1-3 52 57 2-s2.0-70349883924 10.1016/j.ejphar.2009.09.008
14. Kim S. M., Park H. S., Jun D. Y., Woo H. J., Woo M. H., Yang C. H., Kim Y. H., Mollugin induces apoptosis in human Jurkat T cells through endoplasmic reticulum stress-mediated activation of JNK and caspase-12 and subsequent activation of mitochondria-dependent caspase cascade regulated by Bcl-xL. Toxicology and Applied Pharmacology 2009 241 2 210 220 2-s2.0-70350221910 10.1016/j.taap.2009.08.024
15. Jeong G. S., Lee D. S., Kim D. C., Jahng Y., Son J. K., Lee S. H., Kim Y. C., Neuroprotective and anti-inflammatory effects of mollugin via up-regulation of heme oxygenase-1 in mouse hippocampal and microglial cells. European Journal of Pharmacology 2011 654 3 226 234 2-s2.0-79951674708 10.1016/j.ejphar.2010.12. 027
16. Jun D. Y., Han C. R., Choi M. S., Bae M. A., Woo M. H., Kim Y. H., Effect of mollugin on apoptosis and adipogenesis of 3T3-L1 preadipocytes. Phytotherapy Research 2011 25 5 724 731 2-s2.0-79955545476 10.1002/ptr.3329
17. Do M. T., Hwang Y. P., Kim H. G., Na M., Jeong H. G., Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells through modulation of a HER2/Akt/SREBP-1c signaling. Journal of Cell Physiology 2012 228 5 1087 1097
18. Lee S. K., Choi H. I., Yang Y. S., Jeong G. S., Hwang J. H., Lee S. I., Kang K. H., Cho J. H., Chae J. M., Lee S. K., Kim Y. C., Kim E. C., Nitric oxide modulates osteoblastic differentiation with heme oxygenase-1 via the mitogen activated protein kinase and nuclear factor- B pathways in human periodontal ligament cells. Biological and Pharmaceutical Bulletin 2009 32 8 1328 1334 2-s2.0-69149091631 10.1248/bpb.32.1328
19. Lee S. K., Pi S. H., Kim S. H., Min K. S., Lee H. J., Chang H. S., Kang K. H., Kim H. R., Shin H. I., Lee S. K., Kim E. C., Substance P regulates macrophage inflammatory protein 3 α /chemokine C-C ligand 20 (CCL20) with heme oxygenase-1 in human periodontal ligament cells. Clinical and Experimental Immunology 2007 150 3 567 575 2-s2.0-36048948249 10.1111/j.1365-2249.2007.03514. x (Pubitemid 350098737)
20. Pi S. H., Kim S. C., Kim H. T., Lee H. J., Lee S. K., Kim E. C., Defense mechanism of heme oxygenase-1 against cytotoxic and receptor activator of nuclear factor- B ligand inducing effects of hydrogen peroxide in human periodontal ligament cells. Journal of Periodontal Research 2007 42 4 331 339 2-s2.0-34250173125 10.1111/j.1600-0765.2006.00953.x
21. Poss K. D., Tonegawa S., Reduced stress defense in heme oxygenase 1-deficient cells. Proceedings of the National Academy of Sciences of the United States of America 1997 94 20 10925 10930 2-s2.0-0030886054 10.1073/pnas.94.20. 10925 (Pubitemid 27430837)
22. Balogun E., Hoque M., Gong P., Killeen E., Green C. J., Foresti R., Alam J., Motterlini R., Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemical Journal 2003 371 3 887 895 2-s2.0-0037569694 10.1042/BJ20021619 (Pubitemid 36578887)
23. Martin D., Rojo A. I., Salinas M., Diaz R., Gallardo G., Alam J., Ruiz De Galarreta C. M., Cuadrado A., Regulation of heme Oxygenase-1 expression through the phosphatidylinositol 3-kinase/akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. The Journal of Biological Chemistry 2004 279 10 8919 8929 2-s2.0-1542335553 10.1074/jbc.M309660200 (Pubitemid 38295953)
24. Anwar A. A., Li F. Y. L., Leake D. S., Ishii T., Mann G. E., Siow R. C. M., Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. Free Radical Biology and Medicine 2005 39 2 227 236 2-s2.0-20444456655 10.1016/j.freeradbiomed.2005.03.012 (Pubitemid 40814548)
25. Cardinali M., Pietraszkiewicz H., Ensley J. F., Robbins K. C., Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. International Journal of Cancer 1995 61 1 98 103 2-s2.0-0028947575 10.1002/ijc.2910610117
26. Pi S. H., Lee S. K., Hwang Y. S., Choi M. G., Lee S. K., Kim E. C., Differential expression of periodontal ligament-specific markers and osteogenic differentiation in human papilloma virus 16-immortalized human gingival fibroblasts and periodontal ligament cells. Journal of Periodontal Research 2007 42 2 104 113 2-s2.0-33847082493 10.1111/j.1600-0765.2006.00921.x
27. Ghosh S., Karin M., Missing pieces in the NF- B puzzle. Cell 2002 109 S81 S96
28. Suh Y., Afaq F., Johnson J. J., Mukhtar H., A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF- B-signaling pathways. Carcinogenesis 2009 30 2 300 307 2-s2.0-60149112516 10.1093/carcin/bgn269
29. Aggarwal B. B., Nuclear factor B, the enemy within. Cancer Cell 2004 6 3 203 208 10.1016/j.ccr.2004.09.003 (Pubitemid 39222032)
30. Sethi G., Sung B., Aggarwal B. B., Nuclear factor- B activation: from bench to bedside. Experimental Biology and Medicine 2008 233 1 21 31 2-s2.0-37549004392 10.3181/0707-MR-196
31. Bond M., Fabunmi R. P., Baker A. H., Newby A. C., Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF- B. FEBS Letters 1998 435 1 29 34 2-s2.0-0032508674 10.1016/S0014-5793(98)01034-5 (Pubitemid 28432009)
32. Lawson C., Ainsworth M., Yacoub M., Rose M., Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor- B-independent mechanism. Journal of Immunology 1999 162 5 2990 2996 2-s2.0-0033104737 (Pubitemid 29309328)
33. Kerbel R. S., Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000 21 3 505 515 2-s2.0-0034092011 (Pubitemid 30137936)
34. Xiao D., Choi S., Johnson D. E., Vogel V. G., Johnson C. S., Trump D. L., Lee Y. J., Singh S. V., Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004 23 33 5594 5606 2-s2.0-3342895063 10.1038/sj.onc.1207747 (Pubitemid 39093037)
35. She Q. B., Bode A. M., Ma W. Y., Chen N. Y., Dong Z., Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Research 2001 61 4 1604 1610 2-s2.0-0035866404 (Pubitemid 34292594)
36. Brozovic A., Fritz G., Christmann M., Zisowsky J., Jaehde U., Osmak M., Kaina B., Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. International Journal of Cancer 2004 112 6 974 985 2-s2.0-8644269825 10.1002/ijc.20522 (Pubitemid 39507003)
37. Jozkowicz A., Was H., Dulak J., Heme oxygenase-1 in tumors: is it a false friend? Antioxidants and Redox Signaling 2007 9 12 2099 2117 2-s2.0-35848942608 10.1089/ars.2007.1659 (Pubitemid 350059009)
38. Berberat P. O., Dambrauskas Z., Gulbinas A., Giese T., Giese N., Künzli B., Autschbach F., Meuer S., Büchler M. W., Friess H., Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clinical Cancer Research 2005 11 10 3790 3798 2-s2.0-21044452445 10.1158/1078-0432.CCR-04-2159 (Pubitemid 40685598)
39. Hill M., Pereira V., Chauveau C., Zagani R., Remy S., Tesson L., Mazal D., Ubillos L., Brion R., Ashgar K., Mashreghi M. F., Kotsch K., Moffett J., Doebis C., Seifert M., Boczkowski J., Osinaga E., Anegon I., Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB Journal 2005 19 14 1957 1968 2-s2.0-28744447937 10.1096/fj.05-3875com (Pubitemid 41759741)
40. Alam J., Cook J. L., Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Current Pharmaceutical Design 2003 9 30 2499 2511 2-s2.0-0141885079 10.2174/1381612033453730 (Pubitemid 37236369)
41. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., Yamamoto M., Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. The Journal of Biological Chemistry 2000 275 21 16023 16029 2-s2.0-0034717329 10.1074/jbc.275.21.16023 (Pubitemid 30366908)
42. Pi J., Bai Y., Reece J. M., Williams J., Liu D., Freeman M. L., Fahl W. E., Shugar D., Liu J., Qu W., Collins S., Waalkes M. P., Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radical Biology and Medicine 2007 42 12 1797 1806 2-s2.0-34248593492 10.1016/j.freeradbiomed.2007.03.001 (Pubitemid 46754754)
43. Nguyen T., Sherratt P. J., Huang H. C., Yang C. S., Pickett C. B., Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element: degradation of Nrf2 by the 26 S proteasome. The Journal of Biological Chemistry 2003 278 7 4536 4541 2-s2.0-0013282861 10.1074/jbc.M207293200 (Pubitemid 36800950)
44. Sethi G., Sung B., Aggarwal B. B., Nuclear factor- B activation: from bench to bedside. Experimental Biology and Medicine 2006 6 5 515 524
45. Lim J. H., Park H. S., Choi J. K., Lee I. S., Hyun J. C., Isoorientin induces Nrf2 pathway-driven antioxidant response through phosphatidylinositol 3-kinase signaling. Archives of Pharmacal Research 2007 30 12 1590 1598 2-s2.0-38149000858
46. Li W., Khor T. O., Xu C., Shen G., Jeong W. S., Yu S., Kong A. N., Activation of Nrf2-antioxidant signaling attenuates NF B-inflammatory response and elicits apoptosis. Biochemical Pharmacology 2008 76 11 1485 1489 2-s2.0-55949120110 10.1016/j.bcp.2008.07.017
47. Banning A., Brigelius-Flohé R., NF- B, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression. Antioxidants and Redox Signaling 2005 7 7-8 889 899 2-s2.0-22044433408 10.1089/ars.2005.7.889 (Pubitemid 40967140)